• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在中国广西,高效抗逆转录病毒治疗扩大规模八年后,传播的HIV-1耐药性流行率仍然很低。

Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy.

作者信息

Li Guojian, Liang Shujia, Harrison Tim J, Tang Zhenzhu, Shen Zhiyong, Wang Xueyan, Wu Xinghua, Liu Wei, Liang Fuxiong, Feng Liushuai, Yang Jinye, Fang Zhongliao

机构信息

Department of Public Health of Guangxi Zhuang Autonomous Region, Nanning, China.

出版信息

Intervirology. 2014;57(5):270-6. doi: 10.1159/000362366. Epub 2014 Jun 28.

DOI:10.1159/000362366
PMID:24994115
Abstract

OBJECTIVES

Highly-active antiretroviral therapy (HAART) was scaled up in Guangxi, China in 2005. The number of individuals receiving free HAART increased dramatically from June 2010 under the Guangxi Government's anti-HIV programme. We aimed to determine the prevalence of HIV-transmitted drug resistance (TDR) of Guangxi.

METHODS

HIV-positive, antiretroviral-naive individuals were recruited from the east (Hezhou), south (Qinzhou), west (Baise), north (Guilin) and centre (Laibin) of Guangxi. The pol gene of the virus from the individuals was analysed.

RESULTS

The overall prevalence of HIV TDR was 3.2% (7/216, 95% CI 0.9-5.5). The prevalence rates in Baise, Guilin, Hezhou, Qinzhou and Laibin are 4.9% (2/41, 95% CI -1.7 to 11.5), 2.3% (1/44, 95% CI -2.1 to 5.7), 4.7% (2/43, 95% CI -1.6 to 11.0), 2.6% (1/38, 95% CI -2.5 to 7.7) and 2.0% (1/50, 95% CI -1.9 to 5.9), respectively. No significant difference in the prevalence was found among them. No factors were found to be associated with TDR, including CD4 cell counts, viral loads and genotypes. The subtypes CRF01_AE, CRF07_BC, CRF08_BC and B were found. Subtype CRF08_BC is the predominant subtype in Baise while CRF01_AE is the predominant subtype elsewhere in Guangxi.

CONCLUSIONS

The prevalence of TDR in antiretroviral-naive patients in Guangxi remains low 8 years after scale-up of HAART.

摘要

目的

高效抗逆转录病毒疗法(HAART)于2005年在中国广西扩大应用。自2010年6月起,在广西政府的抗艾滋病毒项目下,接受免费HAART治疗的人数急剧增加。我们旨在确定广西艾滋病毒传播耐药性(TDR)的流行情况。

方法

从广西东部(贺州)、南部(钦州)、西部(百色)、北部(桂林)和中部(来宾)招募未接受过抗逆转录病毒治疗的艾滋病毒阳性个体。对这些个体的病毒pol基因进行分析。

结果

艾滋病毒TDR的总体流行率为3.2%(7/216,95%置信区间0.9 - 5.5)。百色、桂林、贺州、钦州和来宾的流行率分别为4.9%(2/41,95%置信区间 - 1.7至11.5)、2.3%(1/44,95%置信区间 - 2.1至5.7)、4.7%(2/43,95%置信区间 - 1.6至11.0)、2.6%(1/38,95%置信区间 - 2.5至7.7)和2.0%(1/50,95%置信区间 - 1.9至5.9)。各地区之间的流行率无显著差异。未发现与TDR相关的因素,包括CD4细胞计数、病毒载量和基因型。发现了CRF01_AE、CRF07_BC、CRF08_BC和B亚型。CRF08_BC亚型是百色的主要亚型,而CRF01_AE亚型是广西其他地区的主要亚型。

结论

HAART扩大应用8年后,广西未接受过抗逆转录病毒治疗患者的TDR流行率仍然较低。

相似文献

1
Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy.在中国广西,高效抗逆转录病毒治疗扩大规模八年后,传播的HIV-1耐药性流行率仍然很低。
Intervirology. 2014;57(5):270-6. doi: 10.1159/000362366. Epub 2014 Jun 28.
2
Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.中国7个城市男男性行为者中1型艾滋病毒感染者非CRF01_AE亚型中与逆转录酶(RT)相关的传播性耐药性增加。
J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):250-5. doi: 10.1097/QAI.0000000000000467.
3
Subtype CRF01_AE dominate the sexually transmitted human immunodeficiency virus type 1 epidemic in Guangxi, China.在中国广西,性传播的人类免疫缺陷病毒 1 型以 CRF01_AE 亚型为主导。
J Med Virol. 2013 Mar;85(3):388-95. doi: 10.1002/jmv.23360.
4
No Difference in Prevalence of Transmitted Drug Resistance between Injection Drug Users and Non-Injection Drug Users: A Cross-Sectional Study among Antiretroviral Treatment-Naïve HIV Patients.在接受抗反转录病毒治疗的 HIV 患者中,注射吸毒者和非注射吸毒者的传播耐药率无差异:一项横断面研究。
Intervirology. 2018;61(6):281-291. doi: 10.1159/000499367. Epub 2019 Apr 24.
5
HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China.中国西南地区新诊断个体中的 HIV 耐药性和 HIV 传播风险因素。
BMC Infect Dis. 2021 Feb 8;21(1):160. doi: 10.1186/s12879-021-05854-w.
6
HIV-1 subtype B/B' and baseline drug resistance mutation are associated with virologic failure: a multicenter cohort study in China.HIV-1 B/B'亚型与基线耐药突变与病毒学失败相关:一项中国多中心队列研究
J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):289-97. doi: 10.1097/QAI.0000000000000473.
7
High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.意大利携带 F1 亚型的患者中 HIV-1 耐药性传播负担高。
J Antimicrob Chemother. 2012 May;67(5):1250-3. doi: 10.1093/jac/dks013. Epub 2012 Feb 1.
8
[Distribution of subtypes of pol gene in HIV-1 epidemic strains in Guangxi Zhuang Autonomous Region, 2010- 2012].[2010 - 2012年广西壮族自治区HIV-1流行毒株中pol基因亚型分布]
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Jan;50(1):79-84. doi: 10.3760/cma.j.issn.0253-9624.2016.01.014.
9
Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China.中国杭州新诊断 HIV 感染者中 HIV-1 的遗传多样性和传播耐药性。
J Med Virol. 2015 Oct;87(10):1668-76. doi: 10.1002/jmv.24223. Epub 2015 Apr 20.
10
The prevalence of antiretroviral multidrug resistance in highly active antiretroviral therapy-treated patients with HIV/AIDS between 2004 and 2009 in South Korea.2004 年至 2009 年韩国接受高效抗逆转录病毒治疗的艾滋病毒/艾滋病患者中抗逆转录病毒药物多重耐药的流行情况。
J Clin Virol. 2014 Jun;60(2):154-60. doi: 10.1016/j.jcv.2014.02.004. Epub 2014 Feb 21.

引用本文的文献

1
Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014-2020.2014-2020 年中国西南部 HIV 阳性个体的预处理 HIV 耐药性和遗传传播网络调查。
BMC Infect Dis. 2021 Nov 12;21(1):1153. doi: 10.1186/s12879-021-06847-5.
2
Using Molecular Transmission Networks to Reveal the Epidemic of Pretreatment HIV-1 Drug Resistance in Guangxi, China.利用分子传播网络揭示中国广西地区治疗前HIV-1耐药性的流行情况。
Front Genet. 2021 Sep 10;12:688292. doi: 10.3389/fgene.2021.688292. eCollection 2021.
3
HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China.
中国西南地区新诊断个体中的 HIV 耐药性和 HIV 传播风险因素。
BMC Infect Dis. 2021 Feb 8;21(1):160. doi: 10.1186/s12879-021-05854-w.
4
The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017.2014 - 2017年中国五个血液中心感染献血者中人类免疫缺陷病毒1型的基因型分布、感染阶段及耐药突变谱
PLoS One. 2020 Dec 21;15(12):e0243650. doi: 10.1371/journal.pone.0243650. eCollection 2020.
5
HIV Epidemiology and Prevention in Southwestern China: Trends from 1996-2017.中国西南部的艾滋病病毒流行病学与预防:1996 - 2017年的趋势
Curr HIV Res. 2019;17(2):85-93. doi: 10.2174/1570162X17666190703163838.
6
Immunological and virologic outcomes of people living with HIV in Guangxi, China: 2012-2017.中国广西地区 HIV 感染者的免疫和病毒学结果:2012-2017 年。
PLoS One. 2019 Mar 1;14(3):e0213205. doi: 10.1371/journal.pone.0213205. eCollection 2019.
7
Comparison of health system responsiveness between HIV and non-HIV patients at infectious disease clinics in Yunnan, China.中国云南传染病诊所中HIV患者与非HIV患者的卫生系统响应性比较。
Patient Prefer Adherence. 2018 Jun 29;12:1129-1137. doi: 10.2147/PPA.S163416. eCollection 2018.
8
The prevalence of drug resistance among treatment-naïve HIV-1-infected individuals in China during pre- and post- 2004.2004年前后中国初治HIV-1感染个体中的耐药流行情况。
BMC Infect Dis. 2016 Oct 26;16(1):605. doi: 10.1186/s12879-016-1928-x.
9
Short Communication: Low False Recent Rate of Limiting-Antigen Avidity Assay Among Long-Term Infected Subjects from Guangxi, China.短讯:中国广西长期感染人群中限制抗原亲和力检测的低假近期率
AIDS Res Hum Retroviruses. 2015 Dec;31(12):1247-9. doi: 10.1089/aid.2015.0097. Epub 2015 Sep 2.
10
Genetic Characteristics of CRF01_AE Among Newly Diagnosed HIV-1-Infected 16- to 25-Year Olds in 3 Geographic Regions of Guangxi, China.中国广西3个地理区域新诊断的16至25岁HIV-1感染青年中CRF01_AE的基因特征
Medicine (Baltimore). 2015 May;94(21):e894. doi: 10.1097/MD.0000000000000894.